DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DAGLUTRIL
2
Small molecule
Investigational
Unknown
Unknown
Hypertension
Endothelin-converting enzyme 1 inhibitor
DAGLUTRIL
×
Maximum Phase:
2
First Approval:
None
UNII:
KKV299446X
Molecule Type:
Small molecule
Molecular Formula:
C31H38N2O6
Molecular Weight:
534.65
AlogP:
4.3
PSA:
113.01
HBD:
2.0
HBA:
#RotB:
11.0
Source:
METHYLINOSITOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYLINOSITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
TF9HZN9T0M
Molecule Type:
Small molecule
Molecular Formula:
C7H14O6
Molecular Weight:
194.18
AlogP:
-3.18
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
INDISULAM
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Leukemia; Melanoma
Unknown
INDISULAM
×
Maximum Phase:
2
First Approval:
None
UNII:
WJ98J3NM90
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O4S2
Molecular Weight:
385.85
AlogP:
2.27
PSA:
122.12
HBD:
3.0
HBA:
#RotB:
4.0
Source:
EZATIOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes
Unknown
EZATIOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
057D10I8S8
Molecule Type:
Small molecule
Molecular Formula:
C27H35N3O6S
Molecular Weight:
529.66
AlogP:
2.5
PSA:
136.82
HBD:
3.0
HBA:
#RotB:
15.0
Source:
CK-2127107
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CK-2127107
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELINZANETANT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELINZANETANT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C33H35F7N4O3
Molecular Weight:
668.65
AlogP:
6.06
PSA:
69.14
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AT7519M
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AT7519M
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLAXSEED
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FLAXSEED
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENTOLIMOD
2
Unknown
Investigational
Unknown
Unknown
Substance-Related Disorders; Neoplasms; Colorectal Neoplasms
Toll-like receptor 5 agonist
ENTOLIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
R1UQ6D1ECM
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMIVIRINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
EMIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
X87G8IX72O
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.24
PSA:
64.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AVADOMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Renal Insufficiency; Melanoma
Unknown
AVADOMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
28DZS29F59
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O3
Molecular Weight:
286.29
AlogP:
0.26
PSA:
107.08
HBD:
2.0
HBA:
#RotB:
1.0
Source:
INT131
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Multiple Sclerosis, Relapsing-Remitting
Peroxisome proliferator-activated receptor gamma modulator
INT131
×
Maximum Phase:
2
First Approval:
None
UNII:
E7ILQ6U50J
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl4N2O3S
Molecular Weight:
514.22
AlogP:
7.44
PSA:
68.29
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MK-7622
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Muscarinic acetylcholine receptor M1 positive allosteric modulator
MK-7622
×
Maximum Phase:
2
First Approval:
None
UNII:
57R7D1Q49R
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O2
Molecular Weight:
399.49
AlogP:
4.32
PSA:
68.01
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DAVALINTIDE ACETATE
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
DAVALINTIDE ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4QM48103XT
Molecule Type:
Protein
Molecular Formula:
C154H252N50O51S2
Molecular Weight:
3684.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NIMACIMAB
2
Antibody
Investigational
Unknown
Unknown
Gastroparesis
Cannabinoid CB1 receptor negative allosteric modulator
NIMACIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
85TS31SOL3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TASIDOTIN HYDROCHLORIDE
2
Protein
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Melanoma; Prostatic Neoplasms, Castration-Resistant
Unknown
TASIDOTIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3382C833Z5
Molecule Type:
Protein
Molecular Formula:
C32H59ClN6O5
Molecular Weight:
643.31
AlogP:
2.09
PSA:
122.37
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PLASMIN (HUMAN)
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PLASMIN (HUMAN)
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANCESTIM
2
Protein
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Anemia, Aplastic; Lymphoma; Multiple Myeloma
Unknown
ANCESTIM
×
Maximum Phase:
2
First Approval:
None
UNII:
PYB4Q6JG41
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-DOS47
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Adenocarcinoma of Lung
Unknown
L-DOS47
×
Maximum Phase:
2
First Approval:
None
UNII:
95E1ZQM329
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASUNERCEPT
2
Protein
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Glioblastoma; Severe Acute Respiratory Syndrome
Tumor necrosis factor ligand superfamily member 6 binding agent
ASUNERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
F333OQQ9UV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-501
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NT-501
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALG-1001
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ALG-1001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L19TNFA
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Fibronectin binding agent
L19TNFA
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-0976
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-0976
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YM-543
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
YM-543
×
Maximum Phase:
2
First Approval:
None
UNII:
KA83KI0EO9
Molecule Type:
Small molecule
Molecular Formula:
C28H37NO7
Molecular Weight:
499.6
AlogP:
1.6
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
4.0
Source:
TYROSINASE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TYROSINASE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-EFLORNITHINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-EFLORNITHINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UO07O10TCJ
Molecule Type:
Small molecule
Molecular Formula:
C6H13ClF2N2O2
Molecular Weight:
218.63
AlogP:
-0.23
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ONO-5334
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-5334
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TGN-1412
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Neoplasms; Psoriasis; Lupus Erythematosus, Systemic
T-cell-specific surface glycoprotein CD28 agonist
TGN-1412
×
Maximum Phase:
2
First Approval:
None
UNII:
POO0DOD3AS
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONO-2333MS
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Corticotropin releasing factor receptor 1 antagonist
ONO-2333MS
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVALEUKIN ALFA
2
Protein
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Graft vs Host Disease; Lupus Erythematosus, Systemic
Unknown
EFAVALEUKIN ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
YNH9K62UXU
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RED CLOVER
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RED CLOVER
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELSUBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
ELSUBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
1487U1Q3IQ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O2
Molecular Weight:
297.36
AlogP:
2.16
PSA:
79.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
3F8
2
Antibody
Investigational
Unknown
Unknown
Neuroblastoma
Disialoganglioside GD2 other
3F8
×
Maximum Phase:
2
First Approval:
None
UNII:
3GFS72WN4M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONC201
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONC201
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
138
139
140
141
142
143
144
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA